Committee Connection
  • Cancer.Net Launches PRE-ACT Patient Clinical Trial Education Program

    24 Feb 2015 05:33 PM

    Clinical trials are the key to driving advances in the prevention, diagnosis, and treatment of cancer, yet it is estimated that only about 5% of patients with cancer participate in clinical trials. Cancer.Net, ASCO’s patient-information website, has teamed up with Neal Meropol, MD, Chief of Hematology and Oncology at University Hospitals Case Medical Center and developer of the Preparatory Education About Clinical Trials (PRE-ACT) program,... Read more

  • Earn MOC Points on the Go with New ASCO MOC App

    24 Feb 2015 05:27 PM

    A new app from ASCO University® enables clinicians to earn Maintenance of Certification (MOC) points quickly, conveniently, and easily by answering questions on a smartphone, tablet, or computer. The ASCO MOC app, available for iOS and Android devices, as well as on a mobile-friendly responsive website, gives users the flexibility to work toward MOC requirements anytime and anywhere that is most convenient for them. The app utilizes... Read more

  • Conquer Cancer Foundation Researcher Spotlights

    24 Feb 2015 05:19 PM

    CCF-supported researchers showcase how your donations are helping to make real progress against cancerConquering Cancer with James D. Murphy, MD, MS  James D. Murphy, MD, MS, an Assistant Professor in the Department of Radiation Medicine at the University of California, San Diego, received a 2012 Conquer Cancer Foundation of ASCO Young Investigator Award (YIA) for his research focusing on access to the delivery of palliative... Read more

  • Five Organizations Awarded 2015 International Innovation Grants

    24 Feb 2015 05:06 PM

    Grants will help improve cancer care in low- and middle-income countries    DONATE TO THE CONQUER CANCER FOUNDATION    to support the next generation of cancer researchers   at The Conquer Cancer Foundation of ASCO (CCF) has announced the five recipients of the 2015 International Innovation Grant. This grant supports novel and innovative projects that may improve diagnosis,... Read more

  • In the News: Select Media Coverage of Recent JCO articles

    24 Feb 2015 04:38 PM

      Karen A. Gelmon, MD  Reuters, November 26, 2014: “The analysis of data on Canadian breast cancer patients offers reassurance that breast cancer survival is improving and also provides updated data to researchers, said the study’s lead author, Dr. Karen Gelmon from the BC Cancer Agency in Vancouver, British Columbia.” —Comparison of Breast Cancer Recurrence and Outcome Patterns Between Patients Treated From 1986 to 1992... Read more

  • New ASCO Study Aims to Learn from Patient Access to Targeted Cancer Drugs Used Off-Label

    23 Feb 2015 12:57 PM

    ASCO plans to launch the first clinical trial in the Society’s history this year. The study will offer patients with cancer access to molecularly targeted cancer drugs and collect real-world data on clinical outcomes to help oncologists learn the best uses of these drugs outside of approved indications.“One of the major challenges to implementing personalized medicine is the lack of information about the risks and benefits of targeted... Read more

  • ASCO Encourages Clinicians, Patients to Consider Phase I Trials as a Treatment Option

    23 Feb 2015 12:52 PM

    ASCO recently updated its 1997 policy statement on the vital importance of phase I clinical trials in oncology. “The Critical Role of Phase I Trials in Cancer Research and Treatment” updated statement emphasizes that these trials offer greater potential as a treatment option for many patients than they did nearly two decades ago, thanks to new molecularly targeted agents and innovative clinical trial designs.This statement, published in... Read more

  • For JCO and JOP, the Age of “Author-Centricity” Is Here

    23 Feb 2015 11:56 AM

    By David Sampson, Senior Director, and Ashley Parker, Editorial Coordinator, ASCO Journals DepartmentMany individuals contribute to the success of the Journal of Clinical Oncology (JCO) and the Journal of Oncology Practice (JOP), but it is the authors who are clearly the lifeblood of the two journals. That is why, for the past 18 months, the ASCO Journals department has been focused on creating a culture of “author-centricity,” defined as... Read more

  • ASCO Names the Transformation of CLL Treatment as the Cancer Advance of the Year

    20 Jan 2015 09:48 AM

    The Clinical Cancer Advances 2015 report features the year’s top achievements, previews future trends   In just a year’s time, four therapies have been approved for patients with chronic lymphocytic leukemia (CLL). The new treatments are more effective and far easier to tolerate than prior therapies. This standout achievement, ASCO’s Advance of the Year, was announced as part of Clinical Cancer Advances 2015: ASCO’s Report on Progress... Read more

  • PQRS Reporting Available at a Discount through ASCO and CECity

    05 Jan 2015 11:24 AM

    ASCO has signed a contract with CECity to provide a substantial discount to eligible professionals (EP) who use CECity’s CMS-approved PQRSwizard registry to fulfill their 2014 reporting requirement. You can now access the PQRSwizard registry to begin meeting your reporting requirement before the February 26, 2015, deadline. CECity’s PQRSwizard registry includes all PQRS-approved measures and measure groups and will support multi-specialty practice... Read more